Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T60182 | ||||
Target Name | Glucagon receptor (GCGR) | ||||
Type of Target |
Successful |
||||
Drug Potency against Target | BI-32169 | Drug Info | IC50 = 440 nM | [1] | |
Des-His1[Glu9]glucagon-NH2 | Drug Info | IC50 = 18 nM | [2] | ||
[des-His1,Tyr5,Glu9,D-Ala10]glucagon-NH2 | Drug Info | IC50 = 510 nM | [3] | ||
[des-His1,Tyr5,Glu9,D-Phe10]glucagon-NH2 | Drug Info | IC50 = 34.5 nM | [3] | ||
[des-His1,Tyr5,Glu9,D-Tyr10]glucagon-NH2 | Drug Info | IC50 = 74 nM | [3] | ||
[des-His1,Tyr5,Glu9]glucagon-NH2 | Drug Info | IC50 = 2.3 nM | [3] | ||
References | |||||
REF 1 | BI-32169, a bicyclic 19-peptide with strong glucagon receptor antagonist activity from Streptomyces sp. J Nat Prod. 2004 Sep;67(9):1528-31. | ||||
REF 2 | Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptor. Bioorg Med Chem Lett. 2005 Mar 1;15(5):1401-5. | ||||
REF 3 | Topographical amino acid substitution in position 10 of glucagon leads to antagonists/partial agonists with greater binding differences. J Med Chem. 1996 Jun 21;39(13):2449-55. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.